The Val66Met polymorphism of the brain-derived neurotrophic factor gene is associated with risk for psychosis: Evidence from a family-based association study

American Journal of Medical Genetics - Neuropsychiatric Genetics

Volumn 141 B, Issue 2, 2006, Pages 135-138

  Rosa, Araceli ^a   Cuesta, Manuel J ^b   Fatjó Vilas, Mar ^a   Peralta, Víctor ^b   Zarzuela, Amalia ^b   Fañanás, Lourdes ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b Universidad Pública de Navarra   (Spain)

Author keywords

Brain derived neurotrophic factor; Family based association study; Prefrontal function; Psychosis; Symptom dimension; WCST, THTB

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; METHIONINE; NEUROTROPHIN; VALINE;

ADULT; ARTICLE; BRAIN DERIVED NEUROTROPHIC FACTOR GENE; BRAIN FUNCTION; CELL REGENERATION; CELL SURVIVAL; COGNITION; CONTROLLED STUDY; EVIDENCE BASED MEDICINE; FAMILY STUDY; FEMALE; GENE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; HUMAN; INHERITANCE; MAJOR CLINICAL STUDY; MALE; NERVE CELL DIFFERENTIATION; NEUROPATHOLOGY; PATHOGENESIS; PHENOTYPE; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN FAMILY; PSYCHOSIS; QUANTITATIVE TRANSMISSION DISEQUILIBRIUM TEST; SYMPTOM; WISCONSIN CARD SORTING TEST;

ADULT; ALLELES; AMINO ACID SUBSTITUTION; ANALYSIS OF VARIANCE; BRAIN-DERIVED NEUROTROPHIC FACTOR; FAMILY HEALTH; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; POLYMORPHISM, GENETIC; RISK FACTORS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 32244434819     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.30266     Document Type: Article

References (31)

1. Abecasis GR, Cardon LR, Cookson WO. 2000. A general test of association for quantitative traits in nuclear families. Am J Hum Genet 66(1):279-292.
2. Andreasen NC, Flaum M, Arndt S. 1992. The Comprehensive Assessment of Symptoms and History (CASH). An instrument for assessing diagnosis and psychopathology. Arch Gen Psychiatry 49(8):615-623.
3. Clayton D. 1999. A generalization of the transmission/disequilibrium test for uncertain-haplotype transmission. Am J Hum Genet 65(4):1170-1177.
4. Egan MF, Goldberg TE, Kolachana BS, Callicott JH, Mazzanti CM, Straub RE, Goldman D, Weinberger DR. 2001. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci USA 98(12):6917-6922.
5. Egan MF, Kojima M, Callicott JH, Goldberg TE, Kolachana BS, Bertolino A, Zaitsev E, Gold B, Goldman D, Dean M, et al. 2003. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112(2):257-269.
6. Franke P, Maier W, Hain C, Klingler T. 1992. Wisconsin Card Sorting Test: An indicator of vulnerability to schizophrenia? Schizophr Res 6(3):243-249.
7. Harrison PJ. 1999. The neuropathology of schizophrenia. A critical review of the data and their interpretation. Brain 122(Pt 4):593-624.
8. Hawi Z, Straub RE, O'Neill A, Kendler KS, Walsh D, Gill M. 1998. No linkage or linkage disequilibrium between brain-derived neurotrophic factor (BDNF) dinucleotide repeat polymorphism and schizophrenia in Irish families. Psychiatry Res 81(2):111-116.
9. Heaton R. 1993. Wisconsin Card Sorting Test Manual. Odessa, Florida: Psychological Assessment Resources, Inc.
10. Hong CJ, Yu YW, Lin CH, Tsai SJ. 2003. An association study of a brain-derived neurotrophic factor Val66Met polymorphism and clozapine response of schizophrenic patients. Neurosci Lett 349(3):206-208.
11. Krebs MO, Guillin O, Bourdell MC, Schwartz JC, Olie JP, Poirier MF, Sokoloff P. 2000. Brain derived neurotrophic factor (BDNF) gene variants association with age at onset and therapeutic response in schizophrenia. Mol Psychiatry 5(5):558-562.
12. Lang UE, Jockers-Scherubl MC, Hellweg R. 2004. State of the art of the neurotrophin hypothesis in psychiatric disorders: Implications and limitations. J Neural Transm 111(3):387-411.
13. Lewin GR, Barde YA. 1996. Physiology of the neurotrophins. Annu Rev Neurosci 19:289-317.
14. Lipska BK, Khaing ZZ, Weickert CS, Weinberger DR. 2001. BDNF mRNA expression in rat hippocampus and prefrontal cortex: Effects of neonatal ventral hippocampal damage and antipsychotic drugs. Eur J Neurosci 14(1):135-144.
15. Mowla SJ, Farhadi HF, Pareek S, Atwal JK, Morris SJ, Seidah NG, Murphy RA. 2001. Biosynthesis and post-translational processing of the precursor to brain-derived neurotrophic factor. J Biol Chem 276(16):12660-12666.
16. Neves-Pereira M, Mundo E, Muglia P, King N, Macciardi F, Kennedy JL. 2002. The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorder: Evidence from a family-based association study. Am J Hum Genet 71(3):651-655.
17. Neves-Pereira M, Cheung JK, Pasdar A, Zhang F, Breen G, Yates P, Sinclair M, Crombie C, Walker N, St Clair DM. 2005. BDNF gene is a risk factor for schizophrenia in a Scottish population. Mol Psychiatry 10(2):208-212.
18. Peralta V, Cuesta MJ. 2001. How many and which are the psychopathological dimensions in schizophrenia? Issues influencing their ascertainment. Schizophr Res 49(3):269-285.
19. Reitan R. 1958. Validity of the trail making test as an indicator of organic brain damage. Percept Mot Skills 8:271-276.
20. Rosa A, Fananas L, Cuesta MJ, Peralta V, Sham P. 2002. Iq21-q22 locus is associated with susceptibility to the reality-distortion syndrome of schizophrenia spectrum disorders. Am J Med Genet 114(5):516-518.
21. Rosa A, Peralta V, Papiol S, Cuesta MJ, Serrano F, Martinez-Larrea A, Fananas L. 2004. Interleukin-1beta (IL-1beta) gene and increased risk for the depressive symptom-dimension in schizophrenia spectrum disorders. Am J Med Genet Part B 124B(1):10-14.
22. Rybakowski JK, Borkowska A, Czerski PM, Skibinska M, Hauser J. 2003. Polymorphism of the brain-derived neurotrophic factor gene and performance on a cognitive prefrontal test in bipolar patients. Bipolar Disord 5:468-472.
23. Sasaki T, Dai XY, Kuwata S, Fukuda R, Kunugi H, Hattori M, Nanko S. 1997. Brain-derived neurotrophic factor gene and schizophrenia in Japanese subjects. Am J Med Genet 74(4):443-444.
24. Seidah NG, Benjannet S, Pareek S, Chretien M, Murphy RA. 1996. Cellular processing of the neurotrophin precursors of NTS and BDNF by the mammalian proprotein convertases. FEBS Lett 379(3):247-250.
25. Spielman RS, McGinnis RE, Ewens WJ. 1993. Transmission test for linkage disequilibrium: The insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 52(3):506-516.
26. Takahashi M, Shirakawa O, Toyooka K, Kitamura N, Hashimoto T, Maeda K, Koizumi S, Wakabayashi K, Takahashi H, Someya T, et al. 2000. Abnormal expression of brain-derived neurotrophic factor and its receptor in the corticolimbic system of schizophrenic patients. Mol Psychiatry 5(3):293-300.
27. Toyooka K, Asama K, Watanabe Y, Muratake T, Takahashi M, Someya T, Nawa H. 2002. Decreased levels of brain-derived neurotrophic factor in serum of chronic schizophrenic patients. Psychiatry Res 110(3):249-257.
28. van Os J, Fahy TA, Jones P, Harvey I, Sham P, Lewis S, Bebbington P, Toone B, Williams M, Murray R. 1996. Psychopathological syndromes in the functional psychoses: Associations with course and outcome. Psychol Med 26(1):161-176.
29. Virgos C, Martorell L, Valero J, Figuera L, Civeira F, Joven J, Labad A, Vilella E. 2001. Association study of schizophrenia with polymorphisms at six candidate genes. Schizophr Res 49(1-2):65-71.
30. Wassink TH, Nelson JJ, Crowe RR, Andreasen NC. 1999. Heritability of BDNF alleles and their effect on brain morphology in schizophrenia. Am J Med Genet 88(6):724-728.
31. Weinberger DR. 1999. Cell biology of the hippocampal formation in schizophrenia. Biol Psychiatry 45(4):395-402.